Literature DB >> 16336120

Alternative pre-mRNA splicing in the human system: unexpected role of repetitive sequences as regulatory elements.

Jingyi Hui1, Albrecht Bindereif.   

Abstract

Alternative splicing is a process by which multiple messenger RNAs (mRNAs) are generated from a single pre-mRNA, resulting in functionally distinct protein products. This is accomplished by the differential recognition of splice sites in the pre-mRNA, often regulated in a tissue- or development-specific manner. Alternative splicing constitutes not only an important mechanism in controlling gene expression in humans, but also an essential source for increasing proteome diversity. In this review we summarize the underlying mechanistic principles, focussing on the cis-acting regulatory elements. In particular, the role of short sequence repeats, which are often polymorphic, in splicing regulation is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336120     DOI: 10.1515/BC.2005.143

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase II.

Authors:  Humaira Gowher; Kevin Brick; R Daniel Camerini-Otero; Gary Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

3.  Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis.

Authors:  Lee-Hsueh Hung; Monika Heiner; Jingyi Hui; Silke Schreiner; Vladimir Benes; Albrecht Bindereif
Journal:  RNA       Date:  2007-12-11       Impact factor: 4.942

4.  Determination and validation of principal gene products.

Authors:  Michael L Tress; Jan-Jaap Wesselink; Adam Frankish; Gonzalo López; Nick Goldman; Ari Löytynoja; Tim Massingham; Fabio Pardi; Simon Whelan; Jennifer Harrow; Alfonso Valencia
Journal:  Bioinformatics       Date:  2007-11-15       Impact factor: 6.937

Review 5.  Post-transcriptional regulation in lymphocytes: the case of CD154.

Authors:  Stefano Vavassori; Lori R Covey
Journal:  RNA Biol       Date:  2009-07-29       Impact factor: 4.652

Review 6.  Clinical, agricultural, and evolutionary biology of myostatin: a comparative review.

Authors:  Buel D Rodgers; Dilip K Garikipati
Journal:  Endocr Rev       Date:  2008-06-30       Impact factor: 19.871

7.  Proteomics studies confirm the presence of alternative protein isoforms on a large scale.

Authors:  Michael L Tress; Bernd Bodenmiller; Ruedi Aebersold; Alfonso Valencia
Journal:  Genome Biol       Date:  2008-11-18       Impact factor: 13.583

8.  Short, synthetic and selectively 13C-labeled RNA sequences for the NMR structure determination of protein-RNA complexes.

Authors:  Philipp Wenter; Luc Reymond; Sigrid D Auweter; Frédéric H-T Allain; Stefan Pitsch
Journal:  Nucleic Acids Res       Date:  2006-06-28       Impact factor: 16.971

Review 9.  Biogenesis and mechanism of action of small non-coding RNAs: insights from the point of view of structural biology.

Authors:  Marina C Costa; Ana Lúcia Leitão; Francisco J Enguita
Journal:  Int J Mol Sci       Date:  2012-08-17       Impact factor: 6.208

10.  Improved identification of enriched peptide RNA cross-links from ribonucleoprotein particles (RNPs) by mass spectrometry.

Authors:  Eva Kühn-Hölsken; Olexandr Dybkov; Björn Sander; Reinhard Lührmann; Henning Urlaub
Journal:  Nucleic Acids Res       Date:  2007-07-25       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.